Merck News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Orderbuch

Analysen

Historisch

10.04.19	AstraZeneca: EU Spproves Lynparza As Monotherapy For Germline BRCA1/2-mutations (RTTNews)
05.04.19	Endo Unit Begins Shipping Generic Version Of Merck's PROVENTIL - Quick Facts (RTTNews)
02.04.19	Merck Reports Successful Completion Of Cash Tender Offer For Immune Design (RTTNews)
01.04.19	Merck Announces Post-hoc Analysis From KEYNOTE-189 Trial - Quick Facts (RTTNews)
01.04.19	AstraZeneca: Selumetinib Gets US Breakthrough Therapy Designation (RTTNews)
26.03.19	Biotech Stocks Facing FDA Decision In April (RTTNews)
20.03.19	Merck To Invest EUR 1 Bln Until 2025 At Darmstadt Site - Quick Facts (RTTNews)
20.03.19	Merck, NGM Bio Extend Broad, Strategic Collaboration To March 2022 (RTTNews)
18.03.19	Merck Announces Label Expansion For KEYTRUDA In Canada - Quick Facts (RTTNews)
14.03.19	Merck: EU Approves KEYTRUDA Plus Chemotherapy To Treat Metastatic Squamous NSCLC (RTTNews)
04.03.19	Merck : EMA Adopts Positive Opinion For KEYTRUDA (RTTNews)
01.03.19	Alzheimer's Trials That Flopped In 2018 (RTTNews)
26.02.19	AstraZeneca, MSD Say Phase III POLO Trial Meets Primary Endpoint Of PFS (RTTNews)
22.02.19	IMDZ Snapped Up, NVRO Falls On Dim Outlook, OPNT Ceases Bulimia Nervosa Trial (RTTNews)
21.02.19	Merck To Buy Immune Design In $300 Mln Deal (RTTNews)
20.02.19	Merck: FDA Grants Priority Review To SBLA For Keytruda Monotherapy (RTTNews)
20.02.19	FDA Nod For NVO's Hemophilia A Drug, ICPT's NASH Trial Hits Goal, NVTA Abuzz (RTTNews)
05.02.19	Merck: FDA To Review Regulatory Filings By Company For Two Antibacterial Agents (RTTNews)
04.02.19	Merck Gets Positive CHMP Opinion For Keytruda In Combination With Chemotherapy (RTTNews)
01.02.19	Merck Q4 Results Beat Estimates (RTTNews)
01.02.19	Merck & Co Inc. Q4 adjusted earnings Beat Estimates (RTTNews)
30.01.19	Merck Receives FDA Breakthrough Therapy Designation For V114 - Quick Facts (RTTNews)
30.01.19	Biotech Stocks Facing FDA Decision In February (RTTNews)
23.01.19	Merck, Tencent Sign Deal On Intelligent Digital Healthcare Services In China (RTTNews)
03.01.19	Merck's KEYTRUDA Gets Five New Approvals In Japan (RTTNews)
03.01.19	Merck Exercises Option For NGM Biopharma's Investigational Insulin Sensitizer (RTTNews)
27.12.18	FDA Approves Sanofi And Merck's Pediatric Hexavalent Combination Vaccine Vaxelis (RTTNews)
24.12.18	Biotech Stocks Facing FDA Decision In January 2019 (RTTNews)
20.12.18	AstraZeneca & Merck & Co.: SOLO-3 Trial Of Lynparza Demonstrates Positive Result (RTTNews)
17.12.18	Merck Announces Approval For KEYTRUDA In Adjuvant Setting In European Union (RTTNews)
14.12.18	Merck To Buy Antelliq For EUR 2.1 Bln Plus Debt Of EUR 1.15 Bln (RTTNews)
13.12.18	Merck, Brazilian Non-profit Organization To Develop Dengue Vaccine (RTTNews)
26.11.18	Biotech Stocks Facing FDA Decision In December (RTTNews)
14.11.18	Merck Says KEYTRUDA Significantly Improves Overall Survival (RTTNews)
12.11.18	AstraZeneca Announces Positive Results From DECLARE-TIMI 58 CV Outcomes Trial (RTTNews)
30.10.18	Merck: FDA Approves KEYTRUDA With Carboplatin, Paclitaxel/Nab-Paclitaxel (RTTNews)
29.10.18	Biotech Stocks Facing FDA Decision In November (RTTNews)
25.10.18	Merck Q3 Profit Tops View, But Sales Miss; Hikes Dividend (RTTNews)
25.10.18	Merck & Co Inc. Q3 adjusted earnings Beat Estimates (RTTNews)
22.10.18	Mark Reports Positive CHMP Opinion For KEYTRUDA - Quick Facts (RTTNews)
21.10.18	AstraZeneca, Merck Announce Results From Phase 3 SOLO-1 Trial On LYNPARZA 300 Mg (RTTNews)
18.10.18	Merck Says Pivotal Phase 3 KEYNOTE-426 Trial Meets Both Primary Endpoints (RTTNews)
16.10.18	AstraZeneca, Merck Announce Fourth Orphan Drug Designation For LYNPARZA (RTTNews)
16.10.18	AstraZeneca, Merck Get FDA's ODD For Lynparza For Pancreatic Cancer (RTTNews)
04.10.18	Merck: DELSTRIGO Meets Primary Efficacy Endpoint In Phase 3 DRIVE-SHIFT Study (RTTNews)
28.09.18	Biotech Stocks Facing FDA Decision In October (RTTNews)
26.09.18	Merck CEO Kenneth Frazier To Remain In His Position Beyond Dec. 2019 (RTTNews)
18.09.18	Pharma Companies Avoid $3.8 Bln In Tax Per Year, Says Oxfam (RTTNews)
12.09.18	Merck: FDA Grants Priority Review To New SBLA For KEYTRUDA - Quick Facts (RTTNews)
11.09.18	Merck: ZERBAXA Meets Primary Endpoints In Phase 3 Study - Quick Facts (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

UBS Group	31.13	2.91 %	K V
Geberit	505.80	2.47 %	K V
ABB	50.70	2.09 %	K V
Holcim	87.22	2.06 %	K V
CieFinRichemont	163.75	1.21 %	K V
Swisscom	512.50	0.10 %	K V
Sonova Hldg	302.60	-0.40 %	K V
Logitech Intl	79.70	-0.62 %	K V
Roche Hldg G	265.40	-1.19 %	K V
Novartis	89.32	-1.40 %	K V

mehr

17.01.25		NYSE-Handel: Dow Jones legt zum Handelsende zu
17.01.25		Starker Wochentag in New York: Dow Jones auf grünem Terrain
17.01.25		Zuversicht in New York: S&P 500 mit Zuschlägen
17.01.25		Aufschläge in New York: S&P 500-Anleger greifen zu
17.01.25		Gewinne in New York: Dow Jones im Plus

17.01.25

NYSE-Handel: Dow Jones legt zum Handelsende zu

17.01.25

Starker Wochentag in New York: Dow Jones auf grünem Terrain

17.01.25

Zuversicht in New York: S&P 500 mit Zuschlägen

17.01.25

Aufschläge in New York: S&P 500-Anleger greifen zu

17.01.25

Gewinne in New York: Dow Jones im Plus